NOCD
PrivateLast Round
Series C
Jan 31, 2023
Est. Valuation
$19.96M
Total Funding Raised
$84M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
NOCD is a mental health technology company that provides a telehealth platform for the treatment of obsessive-compulsive disorder through evidence-based exposure and response prevention therapy.
Sector
Healthcare & Life Sciences
Verticals
Mental Health, Telemedicine, Patient Engagement
Business Model
B2B2C
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NOCD Comparables
Compare NOCD with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| InStride Health | 78% | |
| Talkiatry | 77% | |
| Octave | 76% | |
NOCD Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jan 31, 2023 | ||||
| Series B | Sep 21, 2021 | ||||
| Series A | Oct 8, 2020 | ||||
| Series A | Oct 1, 2019 | ||||
| Seed | Feb 12, 2018 |
Key People
Founding team and executive leadership
NOCD Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Longitude Capital | Series C |
| Meridian Street Capital | Series A |
| Chicago Ventures | Series A, Series B |
| Benz Capital | Series C |
| Kaiser Permanente Ventures | Series C, Series B |
| F-Prime Capital | Series C, Series B |
| 7wire Ventures | Series A, Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 28, 2026
Acquired virtual trauma therapy provider Rebound Health.
- May 6, 2025
Achieved 90% commercial insurance coverage in the U.S.
NOCD Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about NOCD's valuation, stock price, and market status.